ATC Group: A07BA01 Medicinal charcoal

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07BA01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Intestinal adsorbents
4
Charcoal preparations
5
A07BA01
Medicinal charcoal

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
5 g

Active ingredients in A07BA01

Active Ingredient
Description

Activated charcoal is a form of carbon processed to have small, low-volume pores that increase the surface area available for adsorption or chemical reactions.

Medicines in this ATC group

Drug
Countries

Hong Kong

France Tunisia

Cyprus Finland Ireland United Kingdom

New Zealand

Hong Kong Singapore United Kingdom

Austria Lithuania Netherlands Singapore

France Tunisia

Cyprus Singapore

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK